Celcuity

$9.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.54 (+5.78%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Celcuity and other stocks, options, and ETFs commission-free!

About CELC

Celcuity Inc. Common Stock, also called Celcuity, is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN. The listed name for CELC is Celcuity Inc. Common Stock.

CEO
Brian F. Sullivan
Employees
27
Headquarters
Minneapolis, Minnesota
Founded
2012
Market Cap
101.84M
Price-Earnings Ratio
Dividend Yield
Average Volume
14.63K
High Today
$9.89
Low Today
$9.22
Open Price
$9.22
Volume
18.80K
52 Week High
$12.70
52 Week Low
$4.03

Collections

CELC Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like